Temasek completed a $73m investment in Integrace, a pharmaceuticals-focused platform. True North, an independent, wealth management firm, partially offloaded its stake after this transaction but continues to hold a majority stake. "Our approach has been to have sustainable and differentiated scientific practices which build bigger brands, potentially number one or number two in their respective markets," Kedar Rajadnye, Integrace CEO.